Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Liver resection is a therapeutic option for highly selected BCLC C patients in the context of an expert multidisciplinary setting.

Cillo U.

Dig Liver Dis. 2013 Jun;45(6):460-1. doi: 10.1016/j.dld.2013.03.010. Epub 2013 May 6. No abstract available.

PMID:
23660077
2.

External validation of a simplified BCLC staging system for early hepatocellular carcinoma.

Santambrogio R, Salceda J, Costa M, Kluger MD, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D.

Eur J Surg Oncol. 2013 Aug;39(8):850-7. doi: 10.1016/j.ejso.2013.05.001. Epub 2013 May 29.

PMID:
23726257
3.

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Cillo U; Italian Liver Cancer (ITA.LI.CA) group.

J Hepatol. 2015 Mar;62(3):617-24. doi: 10.1016/j.jhep.2014.10.037. Epub 2014 Oct 30.

PMID:
25450706
4.

Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma.

Renner P, Schuhbaum J, Kroemer A, Zeman F, Loss M, Lang SA, Geissler EK, Schlitt HJ, Farkas SA.

Langenbecks Arch Surg. 2016 Feb;401(1):43-53. doi: 10.1007/s00423-015-1359-y. Epub 2015 Dec 1.

PMID:
26627084
5.

Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.

Furukawa K, Shiba H, Horiuchi T, Shirai Y, Haruki K, Fujiwara Y, Sakamoto T, Gocho T, Yanaga K.

J Hepatobiliary Pancreat Sci. 2017 Apr;24(4):199-205. doi: 10.1002/jhbp.436. Epub 2017 Mar 12.

PMID:
28160422
6.

Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).

Bell R, Pandanaboyana S, Lodge JPA, Prasad KR, Jones R, Hidalgo E.

Langenbecks Arch Surg. 2017 Jun;402(4):575-583. doi: 10.1007/s00423-016-1475-3. Epub 2016 Jul 25.

PMID:
27456677
7.

Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?

Chang WT, Kao WY, Chau GY, Su CW, Lei HJ, Wu JC, Hsia CY, Lui WY, King KL, Lee SD.

Surgery. 2012 Nov;152(5):809-20. doi: 10.1016/j.surg.2012.03.024. Epub 2012 Jul 3.

PMID:
22766361
8.

Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

Lin CT, Hsu KF, Chen TW, Yu JC, Chan DC, Yu CY, Hsieh TY, Fan HL, Kuo SM, Chung KP, Hsieh CB.

World J Surg. 2010 Sep;34(9):2155-61. doi: 10.1007/s00268-010-0598-x.

PMID:
20407768
9.

A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.

Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M.

Ann Surg. 2013 May;257(5):929-37. doi: 10.1097/SLA.0b013e31828329b8.

PMID:
23426336
11.

Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

Kim H, Ahn SW, Hong SK, Yoon KC, Kim HS, Choi YR, Lee HW, Yi NJ, Lee KW, Suh KS; Korean Liver Cancer Association.

Br J Surg. 2017 Jul;104(8):1045-1052. doi: 10.1002/bjs.10541. Epub 2017 May 8.

PMID:
28480964
12.

[Advances in surgical therapy for hepatocellular carcinoma].

Hasegawa K, Kokudo N, Makuuchi M.

Gan To Kagaku Ryoho. 2004 Dec;31(13):2110-3. Japanese.

PMID:
15628753
13.

Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.

Wada H, Eguchi H, Noda T, Ogawa H, Yamada D, Tomimaru Y, Tomokuni A, Asaoka T, Kawamoto K, Gotoh K, Marubashi S, Umeshita K, Nagano H, Doki Y, Mori M.

Surgery. 2016 Nov;160(5):1227-1235. doi: 10.1016/j.surg.2016.05.023. Epub 2016 Jul 7.

PMID:
27395761
14.

Surgical resection for hepatocellular carcinoma: Moving from what can be done to what is worth doing.

Romagnoli R, Mazzaferro V, Bruix J.

Hepatology. 2015 Aug;62(2):340-2. doi: 10.1002/hep.27831. Epub 2015 May 29. No abstract available.

15.

Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ.

Ann Surg. 2014 Aug;260(2):329-40. doi: 10.1097/SLA.0000000000000236.

PMID:
24096763
16.

Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging.

Yang T, Lin C, Zhai J, Shi S, Zhu M, Zhu N, Lu JH, Yang GS, Wu MC.

J Cancer Res Clin Oncol. 2012 Jul;138(7):1121-9. doi: 10.1007/s00432-012-1188-0. Epub 2012 Mar 10.

PMID:
22402598
17.

Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.

Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Vitali M, Bertuzzo F, De Angelis M, Mantovani G, Iacono C.

World J Gastroenterol. 2014 Jun 28;20(24):7525-33. doi: 10.3748/wjg.v20.i24.7525. Review.

19.

Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.

Wei Q, Tian H, Luo HX, Zhang YC, Deng YN, Yao J, Li H, Chen GH, Yang Y.

Asian J Surg. 2017 Nov;40(6):453-462. doi: 10.1016/j.asjsur.2016.03.001. Epub 2016 Jun 16.

20.

Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified?

Wei S, Hao X, Zhan D, Xiong M, Li K, Chen X, Huang Z.

J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):637. doi: 10.1007/s11596-011-0574-1. Epub 2011 Oct 25.

PMID:
22038353

Supplemental Content

Support Center